Vitamin D in dialysis patients
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks if measuring vitamin D in dialysis patients can lead to better treatment, then gives vitamin D supplements to those who are low. It may help improve your bone and heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage 5 chronic kidney disease and are on dialysis for at least 3 months.
- Your vitamin D level is low (below 30 ng/mL).
- You are not taking a calcimimetic drug (like Sensipar).
- You are not taking an active form of vitamin D (like calcitriol).
- You have not had your parathyroid glands removed or both kidneys removed.
- You are not taking corticosteroids by mouth or IV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a very high dose of vitamin D3 can reduce moderate to severe chronic pain in people on hemodialysis. It may help by improving vitamin D-related pathways that could affect pain, but you must also meet specific health and testing requirements.
This trial compares two vitamin D medicines (doxercalciferol and calcitriol) to see which better controls high parathyroid hormone levels in people on dialysis. If you join, you'll get one of these medicines to help keep your bones and blood minerals healthy.
This trial tests two forms of vitamin D (cholecalciferol and calcifediol) to see which better raises vitamin D levels in people with a deficiency. It may help you if your vitamin D is low, but you don't have osteoporosis or liver/kidney problems.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study tests a medicine called etelcalcetide to see if it can protect vitamin K activity in people with kidney disease and overactive parathyroid glands who are on dialysis. It aims to slow down calcium buildup in blood vessels and reduce heart valve problems.
This trial tests whether taking vitamin D supplements can improve symptoms and quality of life for people with heart failure. It may help reduce inflammation and support heart function.
Hear when a new Vitamin D Deficiency Due to Chronic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.